Green Lifescience

114450 · KOSDAQ · Health Care · SMALL CAP

A new supply contract.

Green Lifescience disclosed a supply contract with Green Chemical, worth US$6.75M, about 24.91% of its recent annual revenue, running through Dec 2026.

Supply contract(Supply contract signed)· FILED 2026-05-13· RCEPT 20260513900542

US$6.75MContract value
24.91%vs. recent revenue
Dec 2026Throughfrom May 2026

Converted at 1 USD ≈ ₩1,489.84 (filing-date rate, 2026-05-13 close)

What happened

Green Lifescience disclosed a supply contract with Green Chemical, worth US$6.75M, about 24.91% of its recent annual revenue, running through Dec 2026.

For context, this single contract equals about 24.91% of the company's most recent annual revenue.

CounterpartyGreen Chemical
Contract valueUS$6.75M
vs. recent revenue24.91%
ThroughDec 2026 (from May 2026)
Filed2026-05-13, Supply contract signed
SourceDART rcept 20260513900542 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-13 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.